|
Contents
|
|
|
|
Brain
Tumors |
|
|
|
Janssen G,
Bode U, Breu H, Dohrn B, Engelbrecht V, Gobel U
Boswellic
acids in the palliative therapy of children with progressive or relapsed brain
tumors
Klin Padiatr 2000 Jul-Aug;212(4):189-95
|
|
|
Kirste S, Treier M, Wehrle SJ, Becker G, Abdel-Tawab M, Gerbeth K, Hug MJ,
Lubrich B, Grosu AL, Momm F.
Boswellia
serrata acts on cerebral edema in patients irradiated for brain tumors: A
prospective, randomized, placebo-controlled, double-blind pilot trial.
Cancer. 2011 Feb
1. doi: 10.1002/cncr.25945. [Epub ahead of print]
.JPG) Abstract |
.gif)
Related articles
|
|
|
Cancer
Research |
|
|
|
Safayhi
H, Boden SE, Schweizer S, Ammon HP
Concentration-dependent
potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase
product formation in stimulated PMNL
Planta Med 2000 Mar;66(2):110-3
|
|
Safayhi H,
Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP
Boswellic
acids: novel, specific, nonredox inhibitors of 5-lipoxygenase
J Pharmacol Exp Ther 1992 Jun;261(3):1143-6
|
|
Syrovets
T, Buchele B, Gedig E, Slupsky JR, Simmet T
Acetyl-boswellic
acids are novel catalytic inhibitors of human topoisomerases I and IIalpha
Mol Pharmacol 2000 Jul;58(1):71-81 (PDF Full
Text)
|
|
|
Glioblastoma |
|
|
|
Mladen
Golubic, Naren Nathoo, Richard A. Prayson, Linda Vargo, Judy Bondar,
Susana Arrigain, Gene H. Barnett
Increased
expression of 5-lipoxygenase in glioblastoma multiforme
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. R4983
|
|
|
Gliomas |
|
|
|
Gati
I, Bergstrom M, Csoka K, Muhr C, Carlsson J
Effects of
the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines
Prostaglandins Leukot Essent Fatty Acids 1990 Jun;40(2):117-24
|
|
Glaser T,
Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M, Weller M
Boswellic acids
and malignant glioma: induction of apoptosis but no modulation of drug
sensitivity
Br J Cancer 1999 May;80(5-6):756-65
|
|
D.
Hager, H. Dziambor, E. M. App, C. Popa, O. Popa, M. Hertlein
The
treatment of patients with high-grade malignant gliomas with RF-hyperthermia
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 470
|
|
Winking
M, Sarikaya S, Rahmanian A, Jodicke A, Boker DK
Boswellic
acids inhibit glioma growth: a new treatment option?
J Neurooncol 2000 Jan;46(2):97-103 (Abstract+)
|
|
|
Metastatic
Tumors
|
|
|
|
D. F. Flavin
A lipoxygenase inhibitor in breast cancer brain metastases
J Neurooncol. 2006 Sep 26; [Epub
ahead of print]
Abstract
|
|
|
Monograph |
|
|
|
Barrie Cassileth
and K. Simon Yeung
Boswellia (Boswellia
Serrata)
01/13/2003
Memorial Sloar-Kettering Cancer Center (HTML Full Text)
|
|
|
Non-Neoplastic
Diseases |
|
|
|
Gupta
I, Parihar A, Malhotra P, Gupta S, Ludtke R, Safayhi H, Ammon HP
Effects of gum
resin of Boswellia serrata in patients with chronic colitis
Planta Med 2001 Jul;67(5):391-5
|
|
|
Non-CNS Tumors |
|
|
|
Jing Y,
Nakajo S, Xia L, Nakaya K, Fang Q, Waxman S, Han R
Boswellic acid
acetate induces differentiation and apoptosis in leukemia cell lines
Leuk Res 1999 Jan;23(1):43-50
|
|
|
Non-steroidal
anti-infl. agent |
|
|
|
Dahmen
U, Gu YL, Dirsch O, Fan LM, Li J, Shen K, Broelsch CE
Boswellic
acid, a potent antiinflammatory drug, inhibits rejection to the same extent as
high dose steroids
Transplant Proc 2001 Feb-Mar;33(1-2):539-41
|
|
Singh GB, Atal CK
Pharmacology
of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal
anti-inflammatory agent
Agents Actions 1986 Jun;18(3-4):407-12
|
|
